Achieve Life Sciences (ACHV) Total Non-Current Liabilities (2010 - 2026)

Achieve Life Sciences (ACHV) has 12 years of Total Non-Current Liabilities data on file, last reported at $21.2 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 33.56% year-over-year to $21.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.2 million (up 33.56% YoY) and the FY2025 annual result came in at $18.7 million, up 12.84% from the prior year.
• Total Non-Current Liabilities advanced to $21.2 million in Q1 2026, from $18.7 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $21.9 million in Q2 2024 to a low of $15.8 million in Q1 2025.
• A 4-year average of $18.6 million and a median of $18.6 million in 2025 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2025 — Total Non-Current Liabilities decreased 21.04% — and 2026, when it jumped 33.56%.
• Tracing ACHV's Total Non-Current Liabilities over 4 years: stood at $20.3 million in 2023, then retreated by 18.26% to $16.6 million in 2024, then increased by 12.84% to $18.7 million in 2025, then grew by 13.04% to $21.2 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $21.2 million (Q1 2026), $18.7 million (Q4 2025), and $18.4 million (Q3 2025), per Business Quant data.